Literature DB >> 6957684

[Acute lymphoblastic leukemia therapy study BFM 79/81 in children and adolescents: intensified reinduction therapy for patients with different risk for relapse].

G Henze, H J Langermann, R Fengler, M Brandeis, K G Evers, H Gadner, L Hinderfeld, A Jobke, B Kornhuber, F Lampert, U Lasson, R Ludwig, S Müller-Weihrich, M Neidhardt, G Nessler, D Niethammer, M Rister, J Ritter, A Schaaff, G Schellong, B Stollmann, J Treuner, W Wahlen, P Weinel, H Wehinger, H Riehm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6957684     DOI： 10.1055/s-2008-1033805

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN： 0300-8630            Impact factor:   1.349


× No keyword cloud information.
  8 in total

1.  Childhood leukemia: cooperative Berlin-Frankfurt-Münster trials in the Federal Republic of Germany.

Authors:  J Ritter; U Creutzig; A Reiter; H Riehm; G Schellong
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia.

Authors:  P Cremer; M Lakomek; W Beck; G Prindull
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

3.  Discontinuing therapy in childhood acute lymphoblastic leukemia treated with a chemoimmunotherapy protocol.

Authors:  Y Komada; E Azuma; H Yamamoto; S Tanaka; K Shimizu; H Kamiya; M Sakurai; T Izawa
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Hepatitis B vaccination and immune response in children with malignant diseases.

Authors:  U Entacher; O Jürgenssen; L Thun-Hohenstein; G Simbruner; A Khoss; H Wank; G Neuwirth; H Gadner; W Frisch-Niggemeyer
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

5.  Intermediate-dose methotrexate in the treatment of childhood acute lymphocytic leukaemia: lack of benefit during maintenance therapy following intensive induction therapy.

Authors:  G E Janka-Schaub; K Winkler; H Jürgens; U Goebel; P Gutjahr; H J Spaar
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

6.  6-Mercaptopurine in cerebrospinal fluid during oral maintenance therapy of children with acute lymphoblastic leukemia.

Authors:  S Hayder; P Lafolie; O Björk; L Ahström; C Peterson
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 7.  An odyssey in search of a cure: the evolution of treatment of childhood acute lymphoblastic leukemia in the United Kingdom.

Authors:  V Saha; T Eden
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

8.  Bone marrow transplantation for acute leukemia in second or subsequent remission.

Authors:  P Ostendorf; G Ehninger; M L Kallmayer; H Link; K Schüch; K Wilms; C Müller; P Wernet; H Dopfer; D Niethammer
Journal:  Klin Wochenschr       Date:  1984-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.